Back to company

SPECIFIC PHARMA A/S: Financial statements 2018

CVR: 33161395

SPECIFIC PHARMA A/S (CVR 33161395) has filed annual accounts for 2018. In 2018, the company reported revenue of DKK 145,726,000 and a net result of DKK 14,821,000 compared with DKK 26,240,000 the year before. That is an increase of 2.3% compared with the year before. The profit margin was 10.2%. Equity amounted to DKK 69,734,000. The solvency ratio was 79.8%. The company had 12 employees in the financial year.

Revenue
145,726,000 kr.
Gross Profit
29,736,000 kr.
Profit/Loss
14,821,000 kr.
Equity
69,734,000 kr.
Total Assets
87,351,000 kr.
Employees
12

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2018145.7 mio.29.7 mio.14.8 mio.69.7 mio.12
2017142.4 mio.41.9 mio.26.2 mio.74.6 mio.8
2016141.1 mio.-20.2 mio.63.5 mio.8
2015132 mio.35.9 mio.24.1 mio.61.4 mio.4
2014137.8 mio.30.3 mio.18.7 mio.37.3 mio.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Keep an eye on SPECIFIC PHARMA A/S

Get notified instantly about new financial statements, ownership changes, management changes and status changes.

Set up monitoring

About SPECIFIC PHARMA A/S

SPECIFIC PHARMA A/S is a Danish company of the type Aktieselskab based in København SV, founded in 2010. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Uffe Kåre Jensen. The company is owned by NOMECO A/S. The company has 24 employees. In 2026, the company reported revenue of DKK 157,797,000 and a net result of DKK 15,192,000 compared with DKK 29,239,000 the year before. Equity amounted to DKK 98,645,000.